ecrin-mdr-crcClinical2014Colorectal Cancer Stage IVColorectal NeoplasmsColorectal Cancer Stage IvColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2203395Italy4ChemotherapyMetabolic responsePETECRIN MDRActive, not recruitingfalsePET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical TreatmentThe purpose of this study is to test whether an early metabolic response, measured by PET/CT scan after the first cycle of chemotherapy, is able to predict which patients with advanced CRC have a better prognosis.2014-04-152203395NCT02618850